The purpose of the study is to determine whether topical application of rapamycin can lead to
reduction in size and/or number of fibrofolliculomas in BHD patients and may prevent the
growth of new ones. Secondary we evaluate rapamycin safety, formula acceptance and patient
satisfaction.